Cancer Drug Shortages Continue to Put Patients at Risk
Drug shortages are not just a supply chain issue. They are a patient issue.
In new coverage from The National Desk’s Spotlight on America, childhood cancer survivor Abby Bray shares her story of facing drug shortages during her treatment and the uncertainty of not knowing whether the medicines she needed would be available.
““It was almost a dooming feeling. Like, what happens if I don’t get this?””
Abby was Patient One, the experience that inspired her mother, Angels for Change Founder Laura Bray, to take action and advocate for patients facing shortages nationwide. Today, Abby and Laura continue that work together, pushing for solutions that strengthen the pharmaceutical supply chain and put patients first.
The story also examines ongoing shortages of critical cancer medicines, barriers to domestic production, and the need for meaningful policy change to prevent shortages before patients are affected.
We are grateful to The National Desk and Spotlight on America for amplifying Abby’s story and helping shine a light on why we must continue to March Forth toward a more reliable supply of lifesaving medicines.
Watch Abby's full story below:
If you or a loved one is experiencing a drug shortage, Angels for Change is here to help through our Drug Shortage Hotline. Call the Angels for Change Drug Shortage Hotline at (813) 501-7742 to connect with support and resources to help you find the medication you need.
Cancer drug shortages threaten lives as efforts to prevent them hit regulatory red tape
Spotlight on America shares Abby Bray’s story for the first time, revealing how cancer drug shortages impacted her treatment and continue to put patients at risk today. The report also examines the regulatory and supply chain barriers standing in the way of a more reliable supply of essential medicines.
🔗 Read The New York Times Article: https://bit.ly/4idK9N5
Source: The National Desk’s Spotlight on America, reported by Lisa Fletcher, Andrea Nejman, and Nathan Aaron.
